Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02923921
What this trial is testing

Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eli Lilly and Company 567
Early research (Phase 1)Study completedNCT02620800
What this trial is testing

Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreas Adenocarcinoma
Celgene 12
Testing effectiveness (Phase 2)UnknownNCT06543836
What this trial is testing

CtDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07691489
What this trial is testing

Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer

Who this might be right for
Colorectal CancerAdenocarcinoma of the ColonAdenocarcinoma of the Rectum
Memorial Sloan Kettering Cancer Center 27
Testing effectiveness (Phase 2)UnknownNCT05659290
What this trial is testing

Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Nanfang Hospital, Southern Medical University 40
Testing effectiveness (Phase 2)UnknownNCT06434090
What this trial is testing

Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 74
Testing effectiveness (Phase 2)Study completedNCT02052778
What this trial is testing

TAS-120 in Patients With Advanced Solid Tumors

Who this might be right for
CholangiocarcinomaUrothelial CancerAdvanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors+3 more
Taiho Oncology, Inc. 407
Not applicableActive Not RecruitingNCT05579340
What this trial is testing

Postoperative Exercise Training and Colorectal Cancer Liver Metastasis

Who this might be right for
Cancer Metastatic to LiverCancer Colorectal
Rigshospitalet, Denmark 66
Early research (Phase 1)Study completedNCT02368860
What this trial is testing

OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
National Cancer Centre, Singapore 33
Large-scale testing (Phase 3)Active Not RecruitingNCT05506943
What this trial is testing

CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGall Bladder Cancer+1 more
Compass Therapeutics 168
Not applicableWithdrawnNCT06929338
What this trial is testing

XDRIVE in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colon CancerMetastatic Rectal Adenocarcinoma+2 more
First Ascent Biomedical Inc.
Large-scale testing (Phase 3)Study completedNCT00012389
What this trial is testing

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sanofi
Early research (Phase 1)Looking for participantsNCT07349043
What this trial is testing

A Prospective, Safety, and Efficacy Clinical Trial of Pressurized Intraperitoneal Aerosol Therapy for Peritoneal Metastasis of Colorectal Cancer

Who this might be right for
Peritoneal MetastasisCRC (Colorectal Cancer)
Second Affiliated Hospital, Zhejiang University, School of Medicine 42
Large-scale testing (Phase 3)Ended earlyNCT03500874
What this trial is testing

Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM

Who this might be right for
Colorectal CancerLiver MetastasesHAI
Sun Yat-sen University 92
Testing effectiveness (Phase 2)Study completedNCT05742750
What this trial is testing

A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer

Who this might be right for
Locally Advanced Biliary Tract CancerMetastatic Biliary Tract Cancer
Sun Yat-sen University 49
Early research (Phase 1)Looking for participantsNCT06983743
What this trial is testing

ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Erasca, Inc. 600
Testing effectiveness (Phase 2)UnknownNCT01167049
What this trial is testing

Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis

Who this might be right for
Gastric Cancer
Peking University Cancer Hospital & Institute 60
Testing effectiveness (Phase 2)Study completedNCT03098550
What this trial is testing

Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 105
Very early researchUnknownNCT06224738
What this trial is testing

Human HER2-targeted Macrophages Therapy for HER2-positive Advanced Gastric Cancer With Peritoneal Metastases

Who this might be right for
Gastric Cancer
First People's Hospital of Hangzhou 9
Early research (Phase 1)Ended earlyNCT03349255
What this trial is testing

Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerLiver Neoplasms+1 more
Aeon Therapeutics (Shanghai) Co., Ltd. 3
Next Page